IRIDEX Director Catalyst Fund Ix L.P Blueline Buys 4,272 Shares (IRIX)
IRIDEX (NASDAQ:IRIX) Director Catalyst Fund Ix L.P Blueline bought 4,272 shares of the stock in a transaction dated Friday, August 29th. The stock was purchased at an average price of $7.92 per share, with a total value of $33,834.24. The purchase was disclosed in a legal filing with the SEC, which is available at this link.
Shares of IRIDEX (NASDAQ:IRIX) traded up 0.13% on Wednesday, hitting $7.97. 4,043 shares of the company’s stock traded hands. IRIDEX has a one year low of $5.77 and a one year high of $11.00. The stock has a 50-day moving average of $7.8 and a 200-day moving average of $8.4. The company has a market cap of $78.7 million and a P/E ratio of 49.44.
IRIDEX Corporation is a worldwide provider of therapeutic based laser systems, delivery devices and consumable instrumentation used to treat eye diseases in ophthalmology.
Receive News & Ratings for IRIDEX Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IRIDEX Co and related companies with Analyst Ratings Network's FREE daily email newsletter.